University–industry collaboration and firm innovation: an empirical study of the biopharmaceutical industry

Tian, Mingyu; Su, Yiwei; Yang, Zhong

doi:10.1007/s10961-021-09877-y

Cited by 21 publications

(18 citation statements)

References 74 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This Institutional Investor and Sustainable University Funding Research Model indicates a new angle of research in institutional investors and alternative funding for universities where more research is required to explore the possibility and process for implementing the model. Although several studies advocated university-industry collaboration [7,[88][89][90][91], this research extends new possibilities in the literature to bridge the gap between industry and educational institutions, bringing greater opportunity for institutions to invest and develop alternative funding for educational institutions for quality education.…”

Section: Academicmentioning

confidence: 85%

Open Innovation of Institutional Investors and Higher Education System in Creating Open Approach for SDG-4 Quality Education: A Conceptual Review

Khan

Johl

Akhtar

et al. 2022

Journal of Open Innovation: Technology, Market, and Complexity

View full text Add to dashboard Cite

The introduction of sustainable development goals has made sustainability a top priority for most nations. This has raised the investment into the educational system for potential growth and for creating an innovation culture in any country; the role of institutional investors in the development of financing clean energy infrastructure, entrepreneurial development, poverty reduction, and driving corporate social responsibility and firm development has been found significant. An intensive literature search of Scopus and the web of science database was explored with different relevant sets of keywords “Institutional investors AND Education”, “Institutional investors” AND “Higher education”, which drew 29 final articles between 2010–2021. This scoping review draws a new open approach for creating alternative sustainable funding for the higher education system and investment opportunities for institutional investors with government intervention. This research becomes the first that shows the road map to the higher education system in creating alternative funding through the proposed Institutional Investor & Sustainable University Funding Governance Code, which will make the higher education system independent and ease the burden on the government, as well as create a huge market opportunity for both players. This research model will scope the collaborative approach towards sustainable development goal 4—Quality education.

show abstract

Section: Academicmentioning

confidence: 85%

Open Innovation of Institutional Investors and Higher Education System in Creating Open Approach for SDG-4 Quality Education: A Conceptual Review

Khan

Johl

Akhtar

et al. 2022

Journal of Open Innovation: Technology, Market, and Complexity

View full text Add to dashboard Cite

show abstract

“…When biopharmaceutical industries were first established, most were standalone companies. Today however, because of the resource intensiveness needed for R&D, the benefits of transnational trade and collaboration among academics, industries, government institutions, and regulators have proved to be a rewarding and cost-saving approach to achieving enterprises’ ambitions to build ecosystems that enable innovation ( Tian et al, 2021 ). Collaboration brings together individual company strengths and experiences, enables the sharing of equipment and knowledge, and facilitates easier market entry.…”

Section: Discussionmentioning

confidence: 99%

Current situation and future development of the biopharmaceutical industry in China: A mixed-method study

et al. 2022

View full text Add to dashboard Cite

Introduction: The biomedical industry has grown significantly both globally and in China; however, there are still challenges. This study aimed at evaluating the biopharmaceutical sector of China, in terms of ability to innovate, current sales volume, investment, and R&D expenditure, as well as providing a case study detailing the progress and challenges of the industry in Shaanxi province.Method: A cross-sectional mixed-method study design was used to generate a comprehensive profile of the nature of biopharmaceutical innovation capacity and development in China by triangulating country-wide survey and interview data from Shaanxi province. Only biopharmaceutical companies that are currently marketing or conducting research and development were eligible for inclusion, and Shaanxi province was selected for conducting the interviews. Categorical and continuous variables were analyzed descriptively. Interviews were thematically analyzed by using NVivo version 12.Results: The analysis includes responses from 77 biopharmaceutical enterprises; the majority (36, 46.8%) are in Eastern China, followed by 26 (33.8%) in Central China. In 2018, the total sales of biological products amounted to 26.28 billion yuan, and in 2019, a slight increase was observed (30.34 billion); the amount doubled in 2020 to about 67.91 billion yuan. The top three biopharmaceutical products on sale in 2020 were Camrelizumab (5.14 billion yuan), human albumin (4.56 billion yuan), and human immunoglobulin for injection (3.78 billion yuan). Expenditure on R&D has also increased; it amounted to 1657.7 million yuan in 2018, which more than doubled in 2019 to 3572.1 million yuan and further increased to 5857.7 million yuan in 2020. Nonetheless, the progress is not uniform across all provinces, as shown from the results from Shaanxi province, because of lack of local government policies that will impact on the funding, incentives, and market share that motivate the producers.Conclusion: China’s biopharmaceutical industry has expand significantly. The increase in sales indicates that there is an increase in demand for biologicals; moreover, R&D funding is increasing. These are key indicators that influence innovation and development. However, the sector’s capacity to innovate and develop needs to be improved, particularly in the western region, where research and production are relatively weak.

show abstract

“…However, as the level of participation deepens, companies can indeed derive benefits from UI collaboration. Furthermore, Tian et al (2022) their findings revealed that UI collaboration can improve a company's innovation performance. However, it is important to note that having more alliances with other companies can hinder the positive impact of UI collaboration on corporate innovation.…”

Section: Theoretical Background and Hypothesis Development 21 Ui Coll...mentioning

confidence: 99%

“…In other words, UI collaboration is essential for forming enterprise IC. UI collaborative behaviors, such as knowledge transfer, knowledge creation, talent exchange and training, social network connection and academic engagement with industries, can aid in the accumulation of corporate IC (Gerdsri and Manotungvorapun, 2021;Perkmann et al, 2021;Tian et al, 2022).…”

Section: Introductionmentioning

confidence: 99%

Innovating from university–industry collaboration: the mediating role of intellectual capital

Yin,

Li,

Chen

et al. 2023

JIC

View full text Add to dashboard Cite

PurposeUniversity–industry (UI) collaboration is essential for knowledge and technology exchange between higher education institutions and industries, enabling enterprises to accelerate innovation. However, few studies have investigated the collaborative innovation mechanism through which UI collaboration can enhance the accumulation of firms' intellectual capital (IC) and how this, in turn, affects their innovation-driven development.Design/methodology/approachDrawing from the knowledge management and collaborative innovation theory, this research proposes a theoretical framework of the inter-organization relationship between enterprises and universities to investigate the influence mechanism of UI collaboration, including academic engagement and commercialization, on corporate performance as well as the mediating role of IC by employing survey that covers 177 UI collaborations.FindingsEmpirical results show that human capital and relational capital fully mediate the relationship between academic engagement UI collaboration and corporate economic performance, while human capital partially mediates the relationship between commercialization UI collaboration and corporate economic performance. Additionally, structural capital and relational capital partially mediate the relationship between academic engagement and corporate innovation performance, while structural capital fully mediates the relationship between commercialization and corporate innovation performance.Originality/valueThis study empirically investigates how academic engagement and commercialization impact corporate performance (i.e. innovation dimension or economic dimension). It uncovers this relationship's underlying mechanism by documenting the IC's mediating impact.

show abstract

University–industry collaboration and firm innovation: an empirical study of the biopharmaceutical industry

Cited by 21 publications

References 74 publications

Open Innovation of Institutional Investors and Higher Education System in Creating Open Approach for SDG-4 Quality Education: A Conceptual Review

Open Innovation of Institutional Investors and Higher Education System in Creating Open Approach for SDG-4 Quality Education: A Conceptual Review

Current situation and future development of the biopharmaceutical industry in China: A mixed-method study

Innovating from university–industry collaboration: the mediating role of intellectual capital

Contact Info

Product

Resources

About